These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 1549234)

  • 1. Heterozygote ornithine transcarbamylase deficiency presenting as symptomatic hyperammonemia during initiation of valproate therapy.
    Honeycutt D; Callahan K; Rutledge L; Evans B
    Neurology; 1992 Mar; 42(3 Pt 1):666-8. PubMed ID: 1549234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproate as a cause of hyperammonemia in heterozygotes with ornithine-transcarbamylase deficiency.
    Leão M
    Neurology; 1995 Mar; 45(3 Pt 1):593-4. PubMed ID: 7898728
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperammonaemic encephalopathy after initiation of valproate therapy in unrecognised ornithine transcarbamylase deficiency.
    Oechsner M; Steen C; Stürenburg HJ; Kohlschütter A
    J Neurol Neurosurg Psychiatry; 1998 May; 64(5):680-2. PubMed ID: 9598692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ornithine transcarbamylase deficiency: adult onset of severe symptoms.
    Gilchrist JM; Coleman RA
    Ann Intern Med; 1987 Apr; 106(4):556-8. PubMed ID: 3826955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproate-induced hyperammonemia - uncovering an underlying inherited metabolic disorder: a case report.
    Mehta S; Tayabali S; Lachmann R
    J Med Case Rep; 2018 May; 12(1):134. PubMed ID: 29769109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperammonemic coma due to parenteral nutrition in a woman with heterozygous ornithine transcarbamylase deficiency.
    Felig DM; Brusilow SW; Boyer JL
    Gastroenterology; 1995 Jul; 109(1):282-4. PubMed ID: 7797025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproate-induced lethal hyperammonaemic coma in a carrier of ornithine carbamoyltransferase deficiency.
    Tokatli A; Coşkun T; Cataltepe S; Ozalp I
    J Inherit Metab Dis; 1991; 14(5):836-7. PubMed ID: 1779634
    [No Abstract]   [Full Text] [Related]  

  • 8. Valproate-induced fatal acute hyperammonaemia-related encephalopathy in late-onset ornithine transcarbamylase deficiency.
    Kazmierski D; Sharma N; O'Leary K; Ochieng P
    BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34035022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyperammonaemic coma after valproate therapy as adult onset of ornithine transcarbamylase deficiency].
    Padilla Mde L; Miguélez M; Riverola A; Bueno J
    Med Clin (Barc); 2002 Feb; 118(5):199. PubMed ID: 11852003
    [No Abstract]   [Full Text] [Related]  

  • 10. Congenital hyperammonemia: symptomatic carrier girl patient and her asymptomatic heterozygous mother for ornithine transcarbamylase (OTC) deficiency: specific enzyme diagnostic and kinetic investigations for the detection of heterozygous genostatus.
    László A; Karsai T; Várkonyi A
    Acta Paediatr Hung; 1991; 31(3):291-7. PubMed ID: 1742044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ornithine transcarbamylase deficiency unmasked because of gastrointestinal bleeding.
    Trivedi M; Zafar S; Spalding MJ; Jonnalagadda S
    J Clin Gastroenterol; 2001 Apr; 32(4):340-3. PubMed ID: 11276280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal cerebral edema from late-onset ornithine transcarbamylase deficiency in a juvenile male patient receiving valproic acid.
    Thakur V; Rupar CA; Ramsay DA; Singh R; Fraser DD
    Pediatr Crit Care Med; 2006 May; 7(3):273-6. PubMed ID: 16575347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal clinical course of ornithine transcarbamylase deficiency in an adult heterozygous female patient.
    Heringlake S; Böker K; Manns M
    Digestion; 1997; 58(1):83-6. PubMed ID: 9018015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of enzyme defect in a case of ornithine transcarbamylase deficiency.
    Qureshi IA; Letarte J; Quellet R
    Diabete Metab; 1978 Dec; 4(4):239-41. PubMed ID: 729890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ornithine transcarbamylase deficiency in females: an often overlooked cause of treatable encephalopathy.
    Pridmore CL; Clarke JT; Blaser S
    J Child Neurol; 1995 Sep; 10(5):369-74. PubMed ID: 7499756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anesthesia management protocol for liver transplantation as treatment for ornithine transcarbamylase deficiency.
    Baba C; Yukimasa S; Yasuno R; Ichiyanagi H; Ninagawa J; Kasuya S; Kasahara M; Horikawa R; Nagasaka Y; Suzuki Y
    Paediatr Anaesth; 2023 Aug; 33(8):620-630. PubMed ID: 37401903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperammonemia in ornithine transcarbamylase-deficient recipients following living donor liver transplantation from heterozygous carrier donors.
    Rahayatri TH; Uchida H; Sasaki K; Shigeta T; Hirata Y; Kanazawa H; Mali V; Fukuda A; Sakamoto S; Kasahara M
    Pediatr Transplant; 2017 Feb; 21(1):. PubMed ID: 27891735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive characterization of ureagenesis in the spf
    Allegri G; Deplazes S; Rimann N; Causton B; Scherer T; Leff JW; Diez-Fernandez C; Klimovskaia A; Fingerhut R; Krijt J; Kožich V; Nuoffer JM; Grisch-Chan HM; Thöny B; Häberle J
    J Inherit Metab Dis; 2019 Nov; 42(6):1064-1076. PubMed ID: 30714172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial ornithine transcarbamylase deficiency associated with recurrent hyperammonemia, lethargy and depressed sensorium.
    Oizumi J; Ng WG; Koch R; Shaw KN; Sweetman L; Velazquez A; Donnell GN
    Clin Genet; 1984 Jun; 25(6):538-42. PubMed ID: 6733950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of serious illness in heterozygotes for ornithine transcarbamylase deficiency.
    Batshaw ML; Msall M; Beaudet AL; Trojak J
    J Pediatr; 1986 Feb; 108(2):236-41. PubMed ID: 3944708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.